News

Synthetic bed sheets are affordable and seem nice at first, but this effortlessly luxe alternative will last longer and help ...
Increasing global temperatures are ruining sleep quality across the world. Sleep apnea, a common breathing disorder, is ...
Currently, obstructive sleep apnea (OSA) is the second most common sleep disorder and affects almost one billion adults globally,1 causing more patients to turn to CPAP therapy as part of their ...
People with insomnia and concomitant obstructive sleep apnea (OSA) represented a fairly common, medically complex group for ...
A higher proportion of sleep medicine providers vs. patients reported CPAP over tirzepatide as their preferred treatment option for comorbid obesity and obstructive sleep apnea, according to data ...
Vivos Therapeutics Inc. (NASDAQ:VVOS) saw its stock soar by 90% following a major regulatory win: the company’s VidaSleep ...
Investing.com -- Vivos Therapeutics Inc . (NASDAQ: VVOS) stock surged 90% after the company announced its VidaSleep oral appliance received approval from the Centers for Medicare & Medicaid Services ...
Important Milestone Clears the Way for Millions of Medicare Beneficiaries with Sleep Apnea to Access Vivos’ Patented and FDA-Cleared Oral Appliance TreatmentLITTLETON, Colo., July 01, 2025 (GLOBE ...
The healthcare sector offers an abundance of high-growth investment opportunities. Companies leveraging artificial ...